Genentech: Phase III Study In Non-Small Cell Lung Cancer Fai

SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY), said that phase III SKYSCRAPER-01 study in PD-L1-High Metastatic Non-Small Cell Lung Cancer did not meet its co-primary

Related Keywords

, Genentech , Roche Group , High Metastatic Non Small Cell Lung Cancer , Hase , Study , Mall , Fell , Young , Dancer , Nails , Feet , Primary , Ndpoint ,